Use of avacopan with a lower dose of glucocorticoids leads to fewer total and serious side effects, as well as infections.

Alaska Native and American Indian adults have a high prevalence of AAV, with distinct clinical characteristics and treatment patterns observed.

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...